PYC Therapeutics Director Rohan Hockings Buys Shares on Market
PYC: $1.80 -5.26% · MC: $1.9B
PYC Therapeutics director Rohan Hockings bought shares on market for approximately $206,000, increasing his direct ordinary shareholding by nearly 39%. The purchase follows director Peter Coleman's on-market acquisition of shares for approximately $202,000 last week. Hockings is also due to receive options and restricted rights under incentive plans, subject to shareholder approval.

Comments